Oric Pharmaceuticals
ORIC
ORIC
70 hedge funds and large institutions have $189M invested in Oric Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 18 increasing their positions, 17 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
6% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 17
2% less capital invested
Capital invested by funds: $192M → $189M (-$3.61M)
8.66% less ownership
Funds ownership: 81.94% → 73.28% (-8.7%)
Holders
70
Holding in Top 10
6
Calls
$163K
Puts
$117K
Top Buyers
| 1 | +$2.19M | |
| 2 | +$2.08M | |
| 3 | +$2.07M | |
| 4 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$1.14M |
| 5 |
Jane Street
New York
|
+$987K |
Top Sellers
| 1 | -$2.36M | |
| 2 | -$1.6M | |
| 3 | -$1.52M | |
| 4 |
O
OrbiMed
New York
|
-$1.33M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$636K |